Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over

Register of interests (MSWord 41 KB)

Final draft guidance

Final draft guidance (PDF 135 KB)

Public committee slides (PDF 983 KB)

Final draft guidance - equality impact assessment (PDF 142 KB)

Committee papers (PDF 6.33 MB)

Final scope (PDF 184 KB)

Final stakeholder list (PDF 161 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 188 KB)

Equality impact assessment (Scoping) (PDF 126 KB)

Draft scope post referral (PDF 201 KB)

Draft matrix post referral (PDF 159 KB)

Topic selection